Amyloids, prions and the inherent infectious nature of misfolded protein aggregates

Trends in Biochemical Sciences

Volumn 31, Issue 3, 2006, Pages 150-155

  Soto, Claudio ^a   Estrada, Lisbell ^a   Castilla, Joaquín ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; HUMAN; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; REVIEW; YEAST;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; DISEASE TRANSMISSION; HUMANS; PRION DISEASES; PRIONS; PROTEIN FOLDING;

EID: 33644816759     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2006.01.002     Document Type: Review

References (71)

1. A.L. Fink Chaperone-mediated protein folding Physiol. Rev. 79 1999 425 449
2. J.W. Kelly Alternative conformations of amyloidogenic proteins govern their behavior Curr. Opin. Struct. Biol. 6 1996 11 17
3. R.W. Carrell, and D.A. Lomas Conformational disease Lancet 350 1997 134 138
4. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329 332
5. C. Soto Protein misfolding and disease; protein refolding and therapy FEBS Lett. 498 2001 204 207
6. C.C. Blake A molecular model of the amyloid fibril Ciba Found. Symp. 199 1996 6 15
7. G.G. Glenner Amyloid deposits and amyloidosis. The β-fibrilloses I N. Engl. J. Med. 302 1980 1283 1292
8. J.D. Sipe, and A.S. Cohen Review: history of the amyloid fibril J. Struct. Biol. 130 2000 88 98
9. J.N. Buxbaum, and C.E. Tagoe The genetics of the amyloidoses Annu. Rev. Med. 51 2000 543 569
10. D.L. Price The value of transgenic models for the study of neurodegenerative diseases Ann. N.Y. Acad. Sci. 920 2000 179 191
11. M. Bucciantini Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
12. C. Soto, and G.P. Saborio Prions: disease propagation and disease therapy by conformational transmission Trends Mol. Med. 7 2001 109 114
13. S.B. Prusiner Prions Proc. Natl. Acad. Sci. U. S. A. 95 1998 13363 13383
14. J. Collinge Prion diseases of humans and animals: their causes and molecular basis Annu. Rev. Neurosci. 24 2001 519 550
15. J. Collinge Variant Creutzfeldt-Jakob disease Lancet 354 1999 317 323
16. C. Soto, and J. Castilla The controversial protein-only hypothesis of prion propagation Nat. Med. 10 2004 S63 S67
17. G. Legname Synthetic mammalian prions Science 305 2004 673 676
18. J. Castilla In vitro generation of infectious scrapie prions Cell 121 2005 195 206
19. D. Westaway Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins Cell 76 1994 117 129
20. J. Castilla Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein J. Neurosci. 24 2004 5063 5069
21. R. Chiesa Neurological illness in transgenic mice expressing a prion protein with an insertional mutation Neuron 21 1998 1339 1351
22. G.P. Saborio Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding Nature 411 2001 810 813
23. B. Caughey Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains Br. Med. Bull. 66 2003 109 120
24. C. Soto Cyclic amplification of protein misfolding: application to prion-related disorders and beyond Trends Neurosci. 25 2002 390 394
25. J.T. Jarrett, and P.T. Lansbury Jr Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73 1993 1055 1058
26. A. Lomakin On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants Proc. Natl. Acad. Sci. U. S. A. 93 1996 1125 1129
27. J.D. Harper, and P.T. Lansbury Jr Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
28. C. Soto Unfolding the role of protein misfolding in neurodegenerative diseases Nat. Rev. Neurosci. 4 2003 49 60
29. M.R. Krebs Observation of sequence specificity in the seeding of protein amyloid fibrils Protein Sci. 13 2004 1933 1938
30. D.C. Gajdusek Nucleation of amyloidogenesis in infectious and noninfectious amyloidoses of brain Ann. N. Y. Acad. Sci. 724 1994 173 190
31. E.M. Sigurdsson Infectivity of amyloid diseases Trends Mol. Med. 8 2002 411 413
32. J.R. Silveira The most infectious prion protein particles Nature 437 2005 257 261
33. D.S. Kryndushkin Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104 J. Biol. Chem. 278 2003 49636 49643
34. R.H. Kimberlin Experimental scrapie in the mouse: a review of an important model disease Sci. Prog. 63 1976 461 481
35. G.C. Telling Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein Proc. Natl. Acad. Sci. U. S. A. 91 1994 9936 9940
36. J. Goudsmit Evidence for and against the transmissibility of Alzheimer disease Neurology 30 1980 945 950
37. H.F. Baker Experimental induction of β-amyloid plaques and cerebral angiopathy in primates Ann. N. Y. Acad. Sci. 695 1993 228 231
38. H.M. Wisniewski Senile dementia of the Alzheimer type: possibility of infectious etiology in genetically susceptible individuals Acta Neurol. Scand. Suppl. 99 1984 91 97
39. P. Brown Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease Ann. Neurol. 35 1994 513 529
40. P. Brown Alzheimer's disease and transmissible virus dementia (Creutzfeldt-Jakob disease) Ann. N. Y. Acad. Sci. 396 1982 131 143
41. A4-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy Mol. Neurobiol. 8 1994 25 39
42. M.D. Kane Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein transgenic mice J. Neurosci. 20 2000 3606 3611
43. L.C. Walker Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice Peptides 23 2002 1241 1247
44. C. Rocken, and A. Shakespeare Pathology, diagnosis and pathogenesis of AA amyloidosis Virchows Arch. 440 2002 111 122
45. J.D. Sipe Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA Biochemistry 24 1985 2931 2936
46. F.C. De Beer Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis Lancet 2 1982 231 234
47. M. Skinner Murine amyloid protein AA in casein-induced experimental amyloidosis Lab. Invest. 36 1977 420 427
48. R. Kisilevsky, and L. Boudreau Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy Lab. Invest. 48 1983 53 59
49. R. Kisilevsky New clothes for amyloid enhancing factor (AEF): silk as AEF Amyloid 6 1999 98 106
50. K. Ganowiak Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice Biochem. Biophys. Res. Commun. 199 1994 306 312
51. K. Johan Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils Proc. Natl. Acad. Sci. U. S. A. 95 1998 2558 2563
52. K. Lundmark Transmissibility of systemic amyloidosis by a prion-like mechanism Proc. Natl. Acad. Sci. U. S. A. 99 2002 6979 6984
53. K. Higuchi Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II Lab. Invest. 72 1995 75 82
54. K. Higuchi Fibrilization in mouse senile amyloidosis is fibril conformation-dependent Lab. Invest. 78 1998 1535 1542
55. Y. Xing Transmission of mouse senile amyloidosis Lab. Invest. 81 2001 493 499
56. Y. Xing Induction of protein conformational change in mouse senile amyloidosis J. Biol. Chem. 277 2002 33164 33169
57. T. Alper Does the agent of scrapie replicate without nucleic acid? Nature 214 1967 764 766
58. T. Alper The exceptionally small size of the scrapie agent Biochem. Biophys. Res. Commun. 22 1966 278 284
59. J.G. Safar Search for a prion-specific nucleic Acid J. Virol. 79 2005 10796 10806
60. S.B. Prusiner Purification and structural studies of a major scrapie prion protein Cell 38 1984 127 134
61. R. Gabizon Immunoaffinity purification and neutralization of scrapie prion infectivity Proc. Natl. Acad. Sci. U. S. A. 85 1988 6617 6621
62. S.B. Prusiner Attempts to restore scrapie prion infectivity after exposure to protein denaturants Proc. Natl. Acad. Sci. U. S. A. 90 1993 2793 2797
63. H. Bueler Mice devoid of PrP are resistant to scrapie Cell 73 1993 1339 1347
64. K.K. Hsiao Spontaneous neurodegeneration in transgenic mice with mutant prion protein Science 250 1990 1587 1590
65. D.A. Kocisko Cell-free formation of protease-resistant prion protein Nature 370 1994 471 474
66. R.B. Wickner [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae Science 264 1994 566 569
67. S. Lindquist Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis Cell 89 1997 495 498
68. H.E. Sparrer Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein Science 289 2000 595 599
69. M.L. Maddelein Amyloid aggregates of the HET-s prion protein are infectious Proc. Natl. Acad. Sci. U. S. A. 99 2002 7402 7407
70. C.Y. King, and R. Diaz-Avalos Protein-only transmission of three yeast prion strains Nature 428 2004 319 323
71. M. Tanaka Conformational variations in an infectious protein determine prion strain differences Nature 428 2004 323 328